Exploring high growth characteristics of CORCEPT THERAPEUTICS INC (NASDAQ:CORT).

Our stock screener has detected a potential breakout setup on CORCEPT THERAPEUTICS INC (NASDAQ:CORT). This breakout pattern is observed when a stock consolidates following a strong upward movement. It's important to note that this pattern is based on technical analysis, and the actual breakout outcome is uncertain. However, it might be worth keeping an eye on NASDAQ:CORT.

Deciphering the Technical Picture of NASDAQ:CORT

As part of its analysis, ChartMill provides a comprehensive Technical Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various technical indicators and properties.

Taking everything into account, CORT scores 10 out of 10 in our technical rating. Both in the recent history as in the last year, CORT has proven to be a steady performer, scoring decent points in every aspect analyzed.

• The long and short term trends are both positive. This is looking good!
• When comparing the yearly performance of all stocks, we notice that CORT is one of the better performing stocks in the market, outperforming 95% of all stocks. We also observe that the gains produced by CORT over the past year are nicely spread over this period.
• CORT is part of the Pharmaceuticals industry. There are 193 other stocks in this industry. CORT outperforms 94% of them.
• CORT is currently trading near its 52 week high, which is a good sign. The S&P500 Index however is also trading near new highs, which makes the performance in line with the market.
• CORT is currently showing a bull flag pattern! A bull flag pattern occurs when prices pull back slightly after a strong rise up. This may be a nice opportunity for an entry.

For an up to date full technical analysis you can check the technical report of CORT

How do we evaluate the setup for NASDAQ:CORT?

ChartMill incorporates a Setup Rating in its analysis, which measures the extent of consolidation in a stock over recent days and weeks. This rating, ranging from 0 to 10, is updated daily and takes into account multiple short-term technical indicators. The current setup rating for NASDAQ:CORT is 7:

CORT has an excellent technical rating and also presents a decent setup pattern. Prices have been consolidating lately. A pullback is taking place, which may present a nice opportunity for an entry. There is a support zone below the current price at 60.07, a Stop Loss order could be placed below this zone.

Some of the high growth metrics of NASDAQ:CORT highlighted

• The quarterly earnings of CORCEPT THERAPEUTICS INC have shown a 46.43% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
• CORCEPT THERAPEUTICS INC has achieved significant quarter-to-quarter (Q2Q) revenue growth of 47.69%, signaling its ability to capture market opportunities and drive top-line expansion. This growth underscores the company's effective execution and its potential for continued success.
• With notable 1-year revenue growth of 39.65%, CORCEPT THERAPEUTICS INC exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for future growth.
• The average next Quarter EPS Estimate by analysts was adjusted by 17.5%, reflecting the evolving market expectations for the company's EPS growth.
• The recent financial report of CORCEPT THERAPEUTICS INC demonstrates a 46.43% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
• The earnings per share (EPS) growth of CORCEPT THERAPEUTICS INC are accelerating: the current Q2Q growth of 46.43% is above the previous year Q2Q growth of -6.67%. Earnings momentum and acceleration are key for high growth systems.
• CORCEPT THERAPEUTICS INC has experienced notable growth in its operating margin over the past year, reflecting improved operational performance. This growth suggests the company's ability to generate higher profits from its core business activities.
• CORCEPT THERAPEUTICS INC has achieved an impressive Return on Equity (ROE) of 22.2%, showcasing its ability to generate favorable returns for shareholders.
• Maintaining a Debt-to-Equity ratio of 0.0, CORCEPT THERAPEUTICS INC demonstrates a conservative financial approach. This signifies the company's focus on minimizing debt burdens while preserving a solid equity position.
• The ownership composition of CORCEPT THERAPEUTICS INC reflects a balanced investor ecosystem, with institutional shareholders owning 82.4%. This indicates a broader market participation and potential for increased trading liquidity.
• CORCEPT THERAPEUTICS INC has consistently surpassed EPS estimates in the last 4 quarters, reflecting its strong financial performance and effective management. This trend suggests the company's ability to generate positive earnings surprises and drive shareholder value.
• CORCEPT THERAPEUTICS INC has exhibited strong Relative Strength(RS) in recent periods, with a current 95.61 rating. This indicates the stock's ability to outperform the broader market and reflects its competitive position. CORCEPT THERAPEUTICS INC shows promising potential for continued price momentum.

Our High Growth Momentum Breakout screen will find you more ideas suited for high growth momentum breakouts.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.